会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 34. 发明申请
    • Method and system for setting cardiac resynchronization therapy parameters
    • 设置心脏再同步治疗参数的方法和系统
    • US20050137630A1
    • 2005-06-23
    • US10744237
    • 2003-12-22
    • Jiang DingYinghong YuBruce KenKnight
    • Jiang DingYinghong YuBruce KenKnight
    • A61N1/362A61N1/368
    • A61N1/3627A61N1/3682A61N1/3684
    • A method or system for computing and/or setting optimal cardiac resynchronization pacing parameters as derived from intrinsic conduction data is presented. The intrinsic conduction data includes intrinsic atrio-ventricular and interventricular delay intervals which may be collected via the sensing channels of an implantable cardiac device. Among the parameters which may be optimized in this manner are an atrio-ventricular delay interval and a biventricular offset interval. In one of its aspects, the invention provides for computing optimum pacing parameters for patients having some degree of AV block or with atrial conduction deficits. Another aspect of the invention relates to a pacing mode and configuration for providing cardiac resynchronization therapy to patients with a right ventricular conduction disorder.
    • 提出了一种用于计算和/或设置从内在传导数据导出的最佳心脏再同步起搏参数的方法或系统。 内在传导数据包括可通过可植入心脏装置的感测通道收集的本征心室和室间延迟间隔。 可以以这种方式优化的参数是心房延迟间隔和双心室偏移间隔。 在其一个方面,本发明提供了对具有一定程度的AV阻滞或具有心房传导缺陷的患者计算最佳起搏参数。 本发明的另一方面涉及用于向患有右心室传导障碍的患者提供心脏再同步治疗的起搏模式和配置。
    • 37. 发明授权
    • Patient identification for the pacing therapy using LV-RV pressure loop
    • 使用LV-RV压力回路进行起搏治疗的患者鉴定
    • US06280389B1
    • 2001-08-28
    • US09439228
    • 1999-11-12
    • Jiang DingYinghong YuJulio Spinelli
    • Jiang DingYinghong YuJulio Spinelli
    • A61B5021
    • A61N1/365A61N1/3622A61N1/3627A61N1/37
    • A method and apparatus for determining whether a patient with congestive heart failure (CHF) will benefit from pacing therapy through the use of an implantable cardiac rhythm management device. A patient's right ventricular and left ventricular pressures are measured, and the patient's PP_Area is calculated for each normal heartbeat that occurs during the testing period. Depending upon the value of the patient's mean PP_Area, it can be determined whether the patient will or will not respond well acutely to pacing therapy. A mean PP_Area value of greater than or equal to a predetermined threshold, which is about 0.3, indicates that the patient is a responder to pacing therapy, while a value of less than the predetermined threshold of about 0.3 indicates that the patient is a non-responder.
    • 一种用于确定患有充血性心力衰竭(CHF)的患者是否将通过使用植入式心律管理装置从起搏治疗中受益的方法和装置。 测量患者的右心室和左心室压力,并计算在测试期间发生的每个正常心跳的患者的PP_Area。 根据患者平均PP_Area的价值,可以确定患者是否会或不会对起搏治疗产生很好的反应。 大于或等于预定阈值(约0.3)的平均PP_Area值表示患者是起搏治疗的应答​​者,而小于约0.3的预定阈值的值表示患者是非 - 响应者。
    • 38. 发明授权
    • Automatic determination of chronotropic incompetence using atrial pacing at rest
    • 使用心房起搏静息自动确定时间性无能力
    • US09132275B2
    • 2015-09-15
    • US13290362
    • 2011-11-07
    • Yinghong YuDonald L. HopperJiang DingJames O. Gilkerson
    • Yinghong YuDonald L. HopperJiang DingJames O. Gilkerson
    • A61N1/36A61N1/368
    • A61N1/3682
    • An apparatus comprises an implantable cardiac signal sensing circuit that provides an electrical cardiac signal representative of cardiac activity of a subject, an implantable therapy circuit that delivers electrical pacing stimulation energy to a heart of a subject, and a controller circuit. The controller circuit includes a chronotropic incompetence detection circuit that initiates pacing of an atrium of the subject at a rate higher than a device-indicated rate or a sensed intrinsic rate, monitor the AV interval, initiates an increase in the pacing rate while continuing the monitoring of the AV interval, calculates a change in AV intervals between a highest paced rate used in the monitoring and a lowest paced rate used in the monitoring, and indicates that the AV intervals are evidence of chronotropic incompetence when the calculated change in the AV intervals exceeds a specified threshold AV interval change value.
    • 一种装置包括可植入心脏信号感测电路,其提供代表受试者的心脏活动的电心脏信号,将对该对象的心脏发出电起搏刺激能量的可植入治疗电路以及控制器电路。 控制器电路包括一个变时无能检测电路,其以高于设备指示速率或感测到的固有频率的速率启动对象的心房起搏,监视AV间隔,启动起搏速率的增加,同时继续监视 计算AV监视中使用的最高起搏速率和监视中使用的最低起搏速度之间的AV间隔的变化,并且指示AV间隔是当计算出的AV间隔的变化超过时间间隔无能力的证据 指定的阈值AV间隔变化值。